Hey pazy. im not suggesting we align our company values to benefit from vaccine preventable disease. But there is increasing distrust of big pharma and their vaccines. With vaccination rates already dropping, there could be a resurgence in numerous diseases with potentially serious outcomes. E.g. pneumococcal sepsis/ meningitis/ pneumonia. theyre infammatory, autoimmune, fibrotic . less vaccination means more reliance on antibiotics . Then we have a growing issue of antibiotic resistance which would further add to risk of severe progression requiring salvage therapy.
I'm suggesting it may form part of an investment thesis for some. Like those that invest in missile manufacturers. That dont necessarily hope for war and death but know its necessary to defend from conflict or in this case disease.
MSB Price at posting:
$1.85 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)